Navigation For Mobile

Author Archives: Saharsh Davuluri

Non-Cytotoxic Drug Compounds & India’s GMP Schedule M

Drug product volumes have been shrinking as increasingly niche products emerge to treat various conditions. Coupled with the rise of pharmaceutical manufacturing outsourcing, this has led to a reconsideration of…

Posted in APIs, Chemistry, Contract Manufacturing, cytotoxic, drugs, FDA, Neuland Labs, oncology, regulatory, Schedule M | Tagged , , , , | Comments Off on Non-Cytotoxic Drug Compounds & India’s GMP Schedule M

Neuland News: Patent Awards, New Production Blocks and Quality Management

Patent Awards Neuland recently received two IP awards – IP Gems of India 2018 and IP Excellence in India 2018. These awards were presented to Neuland for the Company’s implementation…

Posted in award, IP, Neuland Labs, Patent, QMS, Quality, Unit III | Comments Off on Neuland News: Patent Awards, New Production Blocks and Quality Management

World Environment Day: Beating Plastic

There were many remarkable moments during this year’s World Cup – but the Japanese and Senegal teams and their fans really stand out for non-football-related reasons. They gained global admiration…

Posted in corporate stewardship, green chemistry, Neuland Labs, World Environment Day | Comments Off on World Environment Day: Beating Plastic

Neuland Patent Spotlight: Paliperidone Palmitate & Antipsychotics

The use of anti-psychotic drugs to treat conditions such as schizophrenia and bipolar disorder is on the rise and estimated to reach $18.5 billion by 2022. It is a market…

Posted in Chemistry, DMF, generic, IP, Neuland Labs, Patent, process chemistry | Comments Off on Neuland Patent Spotlight: Paliperidone Palmitate & Antipsychotics

Big Pharma Keeps Getting Bigger…by Shrinking?

An article at Pharma Manufacturing (Shrinking Big Pharma) pointed to the recent movement among Big Pharma towards smaller production floors. It comes as no surprise. With the rise of target-based…

Posted in generic, Uncategorized | Tagged , , | Comments Off on Big Pharma Keeps Getting Bigger…by Shrinking?

Case Studies from Neuland’s Process Engineering Lab

In our PE Lab, a team of 27 highly specialized engineers integrates the key attributes of QbD process understanding, process control, and continuous improvement with advanced equipment, Design of Experiments…

Posted in analytical science, API synthesis, APIs, Capabilities, Chemistry, Design of Experiment, method development, micronization, Neuland Labs, PAT, process chemistry, Process Engineering, QbD, Quality, Route Scouting, Synthesis Route | Comments Off on Case Studies from Neuland’s Process Engineering Lab

Ringing Hyderabad: Neuland’s Home in Genome Valley

With the recent acquisition of Unit III, Neuland’s footprint around Hyderabad continues to grow. Hyderabad, for those not familiar with India’s fourth most populous city, is a hive of finance,…

Posted in Hyderabad, Neuland Labs | Comments Off on Ringing Hyderabad: Neuland’s Home in Genome Valley

Emerging Peptide Technology Spotlight: Molecular Hiving

Earlier this year, Neuland began working with a technology called Molecular HivingTM along with Jitsubo Co. (Read the March 2018 press release here).  It’s a patented technique to manufacture peptides…

Posted in Chemistry, Jitsubo, Molecular Hiving, peptide, peptides, Process Engineering | Comments Off on Emerging Peptide Technology Spotlight: Molecular Hiving

Generic Drugs: Despite Dominance, Consumer Perception Issues Linger

Generics: U.S. Drug Industry Dominance The last time you filled a prescription, was it a generic or a brand name drug? An astonishing 89% of all drug prescriptions in the…

Posted in APIs, drugs, generic, Neuland Labs, Quality, regulatory, supply chain | Comments Off on Generic Drugs: Despite Dominance, Consumer Perception Issues Linger

Neuland Patent Spotlight: Entacapone & Parkinson’s Disease

Treating the Symptoms of Parkinson’s Disease According to the Parkinson’s Foundation, Parkinson’s Disease (PD) affects about one million people in the U.S., and 10 million worldwide. While there is no…

Posted in APIs, drugs, Neuland Labs, Parkinson's | Comments Off on Neuland Patent Spotlight: Entacapone & Parkinson’s Disease